06.05.2024 - MELBOURNE, Australia, May 06, 2024 (GLOBE NEWSWIRE) - Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a global leader in genomics-based tests in health, wellness and serious disease, is pleased to announce the execution of . Seite 1